Stephanie Madia Mobley
About Stephanie Madia Mobley
Stephanie Madia Mobley serves as the Senior Vice President of Strategy Growth and Business Development at Highmark Inc., a position she has held since 2021. With extensive experience in strategy and business development across various companies, she has held multiple leadership roles in her career.
Work at Highmark
Stephanie Madia Mobley has held several key positions at Highmark Inc. since 2018. She currently serves as the Senior Vice President of Strategy Growth and Business Development, a role she has occupied since 2021. Prior to this, she was Vice President of Strategic Growth Initiatives from 2019 to 2021 and Vice President of Medical Cost Initiatives in 2018. Her work at Highmark focuses on developing strategic initiatives that drive growth and improve business operations.
Previous Experience at Philips
Before her tenure at Highmark, Stephanie worked at Philips in various roles related to strategy and business development. She served as Sr. Manager, Strategy and Business Development for one year from 2013 to 2014, and as Manager of Strategy and Business Development for two years from 2011 to 2013. Her experience at Philips contributed to her expertise in strategic planning and business growth.
Education and Expertise
Stephanie Madia Mobley earned a Bachelor of Business Administration (BBA) in Finance from the University of Notre Dame, completing her studies from 2002 to 2006. She further advanced her education by obtaining a Master of Business Administration (MBA) with a focus on Finance, Quantitative Analysis, and Strategy from Carnegie Mellon Tepper School of Business, where she studied from 2007 to 2012. Her educational background supports her roles in strategy and business development.
Early Career Background
Stephanie's early career includes various analytical roles that laid the foundation for her expertise in finance and strategy. She worked as a Financial Analyst and Market Planning Analyst at DICK'S Sporting Goods from 2009 to 2011. Additionally, she held positions as a Sales Analyst at Thermo Fisher Scientific from 2007 to 2009 and as a Leveraged Finance Analyst at BMO Capital Markets from 2006 to 2007. These roles provided her with valuable experience in financial analysis and market strategy.